Waterloo Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
4,321
+1,350
+45% +$281K 0.06% 247
2026
Q1
$628K Sell
2,971
-324
-10% -$69.8K 0.04% 270
2025
Q4
$677K Sell
3,295
-128
-4% -$24.1K 0.05% 254
2025
Q3
$537K Sell
3,423
-310
-8% -$47.9K 0.04% 266
2025
Q2
$627K Buy
3,733
+756
+25% +$112K 0.05% 237
2025
Q1
$410K Buy
+2,977
New +$379K 0.04% 278

Other funds holding CAH

Waterloo Capital's CAH Position: Q2 2026 in Review

Waterloo Capital increased its Cardinal Health (CAH) stake by 45% in Q2 2026, buying an estimated $281K and bringing the position to 4,321 shares worth $1.03M. The position accounts for 0.06% of the portfolio, ranked #247.

Waterloo Capital first reported a position in CAH in Q1 2025 and has held it in 6 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Waterloo Capital held 4,321 shares of Cardinal Health worth $1.03M as of Q2 2026.
  • Waterloo Capital bought 1,350 Cardinal Health shares in Q2 2026, an estimated $281K.
  • Cardinal Health made up 0.06% of Waterloo Capital's portfolio in Q2 2026, its #247 holding.
  • Waterloo Capital first reported a position in Cardinal Health in Q1 2025 and has held it in 6 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.